Assim como os iPhones e iPads, os Apple Watches também possuem um ajuste que pode minimizar os efeitos de destaque e de luz intermitente nas interações com os elementos presentes na tela.

Batizado de Redução dos efeitos de brilho, o recurso veio para minimizar os efeitos do Liquid Glass, já que muita gente não curtiu os elementos introduzidos com as versões 26 dos sistemas operacionais da Maçã.

Veja como habilitar isso no seu smartwatch! ⌚️

Pelo iPhone

Com o app Watch aberto, toque na aba “Meu Relógio” e selecione “Acessibilidade”.

Em seguida, marque a opção “Redução dos efeitos de brilho”.

Pelo Apple Watch

No relógio, abra os Ajustes (Settings), vá até “Acessibilidade” e marque a opção “Redução dos efeitos de brilho”.

NOTA DE TRANSPARÊNCIA: O MacMagazine recebe uma pequena comissão sobre vendas concluídas por meio de links deste post, mas você, como consumidor, não paga nada mais pelos produtos/serviços usando os nossos links de afiliado.

A Apple está testando uma nova interface na beta do macOS Golden Gate 27 que exibe uma série de atalhos da Siri AI sempre que o usuário seleciona texto em um app qualquer.

Descoberta pelo usuário identificado como “pdfu” em uma comunidade do Reddit, a novidade está claramente inacabada, o que explica o fato de ela vir desativada por padrão nas versões mais recentes do sistema operacional.

Como é possível notar abaixo, a interface assume a forma de um popover que aparece no canto superior esquerdo da seleção feita pelo usuário. Além disso, os atalhos são contextuais, o que significa que ações diferentes poderão ser sugeridas dependendo do conteúdo em destaque.

macOS 27 has a hidden "lightweight UI" for Siri AI when selecting text, here's how to enable it
byu/pdfu inMacOSBeta

Caso o usuário esteja trabalhando em um texto, o recurso exibirá atalhos relacionados às Ferramentas de Escrita (Writing Tools), só para citar um exemplo. Ainda de acordo com as informações, o recurso também pode sugerir ações como enviar um email, adicionar um número aos contatos, exibir um endereço no app Mapas (Maps) ou rastrear um voo.

Para testar a novidade, é necessário estar rodando a terceira beta para desenvolvedores ou a primeira beta pública do macOS 27. Feito isso, basta abrir o Terminal, rodar o comando a seguir e reiniciar o Mac:

sudo mkdir -p /Library/Preferences/FeatureFlags/Domain && sudo defaults write /Library/Preferences/FeatureFlags/Domain/WritingTools LightweightUI_macOS -dict Enabled -bool true

Para desativar a novidade (o que talvez se prove necessário, já que, como dito, ela ainda está inacabada e apresenta inconsistências), basta abrir o Terminal novamente, rodar o comando a seguir e reiniciar o Mac:

sudo defaults write /Library/Preferences/FeatureFlags/Domain/WritingTools LightweightUI_macOS -dict Enabled -bool false

Como essa nova interface já está disponível (mesmo que escondida) nas betas do macOS 27, é bem possível que ela dê as caras em uma futura versão de teste do sistema — provavelmente em um estado bem mais polido.

via iThinkDifferent

Our poll results are in: virtually no TidBITS readers use clear or tinted icons on the Mac or the iPhone. But the real issue isn’t color—it’s that Apple’s mandatory squircle shape strips icons of their distinctive personalities, making them harder to differentiate.

Adam Engst at TidBITS took the time to extract every item on the WWDC 2026 keynote slide that captured our attention last week. Even better, Adam grouped the changes into operating systems, apps, and other categories. While the 27 OSes dominate the list with improvements and revisions, you can also note how many changes Apple is making to Photos and Shared Albums, Find My, Music, and a number of other across-the-ecosystem tools.

Then Marcin Wichary used Adam’s post to slice the data in a different way, counting the number of times the slide used words like fast (59 times) and reliable (22 times). Marcin reasonably argues that speed is the easier problem to attack, while reliability is fuzzier and much harder to pin down.

Go to the linked site.

Read on Six Colors.

Brain-computer interfaces (BCIs) have become a major focus of technological innovation in recent months, with China leading the commercialization of the emerging technology. However, neighboring Australia may soon make its own mark, as the University of Melbourne startup Fluent develops a new device designed to transform how people with speech impairments communicate.

Many communication technologies currently available remain limited for people living with neurological conditions such as motor neuron disease and multiple sclerosis. As these conditions progress, many patients experience increasing difficulty speaking and may eventually lose the ability to communicate verbally altogether.

Fluent is developing a different approach from many existing BCI systems. While invasive BCIs require brain surgery to implant electrodes inside the skull, Fluent’s device is designed to sit beneath the scalp but outside the skull, offering what the company hopes will be a safer and more accessible alternative.

“Until now, this technological capability was only thought possible using highly invasive electrodes implanted inside the skull,” said Fluent co-founder and biomedical engineer Dr. Tim Mahoney in a statement.

Mahoney’s research suggests that signals captured by the device are comparable whether electrodes are placed beneath or outside the skull. If validated through further testing, this could represent a significant advance in BCI development, as invasive systems have historically captured higher-quality brain signals and outperformed non-invasive approaches.

“Our device will be positioned above an area of the brain called the motor cortex, which controls speech muscles. If you think of electrical signals as QR codes: when a person speaks, every individual mouth and jaw movement produces different ‘QR codes’ in their motor cortex,” said Mahoney.

“These ‘QR codes’ also occur when a person with impaired speech is attempting to speak. Our device can capture these codes in a sequence, which tells us what someone is trying to say,” Mahoney adds.

The device captures brain signals and records them in sequence, allowing researchers to understand what a person is attempting to communicate. A machine learning system is being developed to translate brain activity into written text or audio by just thinking about speaking.

“After building the largest English dataset of its kind, we partnered with a Japanese team leveraging an even larger dataset,” Mahoney explained. “This collaboration proved that a model can accurately isolate the correct phrase from a pool of 128 options with 96 percent accuracy.”

To date, the technology has undergone preliminary human testing at the Aikenhead Centre for Medical Discovery at St Vincent’s Hospital in Melbourne. During those trials, participants wore a cap fitted with 144 electrodes positioned over the motor cortex while speaking, miming words, and imagining different phrases.

The team’s work resulted in one of the largest English-language brain activity datasets assembled to date. In collaboration with Japanese researchers using an even larger dataset, they demonstrated that an AI model could correctly identify a target phrase from a pool of 128 possibilities with 96% accuracy.

Like other advanced medical technologies, BCIs must undergo rigorous regulatory review before they can be brought to market, and Fluent expects Australia’s approval process to follow internationally recognized standards.

“BCI is a relatively new technology, with the first devices currently being approved in China and the US. The regulatory process for BCI technology follows the same safety and efficacy data requirements used for medical device approval across the various countries’ regulatory bodies. Australia is a fantastic place to perform clinical trials due to its R&D tax incentives, meaning Fluent is well-positioned to streamline our pathway to regulatory clearance,” Mahoney said in an email to The Debrief. 

With China and the United States both advancing minimally invasive BCI technologies toward commercialization, Fluent hopes its approach can distinguish itself by prioritizing accessibility over maximum signal fidelity.

“The field of BCI has made enormous progress in the past 5 years. Neuralink is close to commercializing cursor control, research groups have demonstrated online speech decoding with electrodes placed directly on the brain, and META just released their Brain2Qwerty model that can convert non-invasive ‘typing’ brain activity into text,” says Mahoney. 

“The subscalp speech BCI that Fluent is building will not have the same performance as more invasive devices,” he adds. “However, we believe our solution is far more accessible, given the low-risk, set-and-forget nature of the device.”

“We also believe that our low-risk approach can deliver near-perfect speech decoding performance when paired with context-aware large language models to correct errors in an informed way,” Mahoney said.

Chrissy Newton is a PR professional and the founder of VOCAB Communications. She currently appears on The Discovery Channel and Max and hosts the Rebelliously Curious podcast, which can be found on YouTube and on all audio podcast streaming platforms. Follow her on X: @ChrissyNewton, Instagram: @BeingChrissyNewton, and chrissynewton.com. To contact Chrissy with a story, please email chrissy @ thedebrief.org.

In the ever-evolving field of genomics, a significant leap has been achieved with the introduction of the PGS Browser, a novel public platform designed to transform the way researchers, clinicians, and individuals interact with polygenic scores. Polygenic scores (PGS) are quantitative measures that capture the cumulative effect of numerous genetic variants across the genome, predicting an individual’s predisposition to complex traits and diseases. This new platform promises not just accessibility but also interpretative power, enabling a personalized approach to genomic data that could reshape personalized medicine and risk assessment paradigms worldwide.

At the heart of this transformative tool lies a sophisticated integration of vast genomic datasets, advanced computational algorithms, and user-friendly interfaces. The PGS Browser aggregates polygenic scores derived from an array of large-scale genome-wide association studies (GWAS), providing an unprecedented resource where users can explore the genetic architecture of diverse traits. One of the platform’s most compelling features is its capacity to personalize polygenic risk predictions by incorporating individual genetic data with contextual healthcare analytics, bridging the longstanding gap between raw genetic information and actionable clinical insights.

Traditionally, polygenic scores have been calculated using fixed sets of genetic variants, often constrained by limited population samples or specific ancestral backgrounds. This poses significant challenges regarding the portability and generalizability of these scores across diverse populations. The PGS Browser addresses this limitation head-on by incorporating multi-ancestry datasets and advanced statistical models that recalibrate polygenic scores for diverse genetic ancestries. This opens new horizons in achieving equity in genomic medicine, ensuring individuals from underrepresented populations have access to precise, contextually relevant risk evaluations.

The technical backbone of the PGS Browser involves complex methodologies that include linkage disequilibrium (LD) adjustment, penalized regression frameworks, and machine learning techniques, all optimized for high-throughput and scalable analysis. These computational advances optimize the balance between predictive accuracy and overfitting, a persistent challenge in polygenic score modeling. By dynamically adjusting for confounding genomic features and population stratification, the platform produces risk scores that are both statistically robust and biologically interpretable.

One of the critical innovations within the platform is its interpretability module, designed to unpack the black-box nature of polygenic predictions. Users are not only presented with their personalized polygenic scores but also receive detailed visualizations and annotations explaining the contribution of key genetic loci, biological pathways involved, and potential gene-environment interactions. This level of detail empowers clinicians to make informed decisions and patients to understand the genetic basis of their risks, paving the way for targeted preventative strategies and lifestyle modifications.

From a healthcare perspective, the implications of the PGS Browser extend far beyond academic research. The platform is a strategic tool for genetic counseling, allowing healthcare providers to identify individuals at elevated risk for complex diseases such as cardiovascular disease, diabetes, and certain cancers before clinical symptoms manifest. Early identification through polygenic risk enables preemptive interventions, personalized monitoring, and tailored therapeutic approaches, underscoring a shift from reactive to proactive medicine.

Moreover, the PGS Browser operates with a commitment to transparency and reproducibility, addressing critical concerns in genetic epidemiology. All computational workflows are openly accessible, enabling peer verification and fostering collaborative improvement. The platform also integrates with existing biobank data through standardized protocols, facilitating validation studies and meta-analyses that enhance the reliability of polygenic scores across global cohorts.

A particularly noteworthy aspect of the platform is its potential role in pharmacogenomics. By correlating polygenic scores with drug response phenotypes, the browser could assist in identifying individuals who might benefit from specific medications or require dosage adjustments. This integration with personalized medicine elevates the clinical utility of polygenic scores from risk stratification to therapeutic optimization, highlighting the multi-dimensional impact of genomic data in patient care.

The PGS Browser also bridges the gap between research and public engagement. Designed with intuitive navigation and educational resources, it invites an increasingly genomically literate public to explore their genetic predispositions within a responsible and secure framework. This democratization of genetic information fosters greater awareness and empowerment while maintaining stringent privacy standards, an essential consideration in the era of big data.

In operational terms, the platform boasts scalability features capable of handling millions of individuals’ data concurrently, a necessity given the rapid expansion of genomic databases worldwide. The utilization of cloud-based infrastructures, coupled with containerized computational environments, ensures flexible deployment across various institutional settings while preserving data security and compliance with regulatory frameworks such as GDPR.

From a scientific perspective, the availability of such a public platform catalyzes the discovery of novel gene-trait associations by allowing researchers to perform systematic, large-scale analyses that correlate polygenic scores with phenotypic data. This accelerates the identification of biological mechanisms underlying complex traits, informing subsequent functional studies and therapeutic development pipelines.

Ethical considerations permeate the development and deployment of the PGS Browser. The platform incorporates informed consent modules, guidelines on interpretation limitations, and warnings against deterministic views of genetic risk. By fostering responsible use and interpretation, the platform promotes ethical standards within a field where genetic data can easily be misunderstood or misapplied.

Furthermore, the PGS Browser represents a leap forward in standardizing polygenic score methodologies. Historically, disparate scoring algorithms and variable reporting conventions have hindered comparability across studies. This unified platform offers a harmonized framework that promotes methodological consistency, enabling the scientific community to consolidate findings and build upon a shared foundation.

The cross-disciplinary collaboration manifested in the creation of the PGS Browser highlights the convergence of genetics, bioinformatics, data science, and clinical medicine. This integrative approach is crucial to addressing the complexities of polygenic risk and translating genomic insights into tangible health benefits, marking a pivotal moment in the genomics era.

Looking forward, the PGS Browser sets the stage for continuous evolution. Planned enhancements include integration with longitudinal health records, expansion of trait coverage particularly in psychiatric and neurological domains, and real-time updating as new GWAS data emerge. Such adaptability ensures the platform remains at the forefront of personalized genomics research and application.

In conclusion, the PGS Browser embodies a landmark achievement in the democratization and personalization of polygenic score analysis. By merging rigorous computational techniques with accessible design and ethical mindfulness, it empowers a broad spectrum of users to harness the predictive power of genomic data. This innovation holds transformative potential for healthcare, research, and public understanding, catalyzing a new era in precision medicine where genetic insights are personalized, interpretable, and actionable like never before.

---

Subject of Research: Development and deployment of a public platform for personalized polygenic score analysis and interpretation.

Article Title: PGS Browser: A Public Platform for Personalized Polygenic Score Analysis and Interpretation.

Article References:
Kolosov, N., Reeve, M.P., Briotta Parolo, P.D. et al. PGS Browser: a public platform for personalized polygenic score analysis and interpretation. Nat Commun (2026). https://doi.org/10.1038/s41467-026-74461-7

Image Credits: AI Generated

In the ever-evolving landscape of energy storage technologies, the lithium–sulfur (Li–S) battery stands out for its promise to deliver unmatched energy density and reduced costs compared to traditional lithium-ion batteries. However, progress toward commercial viability has been hampered by complex electrochemical challenges, particularly those involving interfacial charge transfer dynamics. A new study, recently published in Nature, unveils groundbreaking insights into the intricate reaction pathways occurring at solid–liquid interfaces within Li–S batteries, illuminating mechanisms that govern lithium sulfide deposition under realistic, lean electrolyte conditions.

The difficulty in understanding and controlling the conversion of lithium polysulfides (LiPSs) during battery cycling stems largely from the dynamic and highly concentrated nature of reactant distributions at the electrode–electrolyte interface. In these environments, the balance between surface-bound and dissolved species dictates the overall electrochemical performance. The new research deploys advanced in situ liquid-cell electron microscopy techniques to directly visualize these sophisticated concentration gradients, a feat that has eluded scientists due to the liquid phase’s complexity and the scales involved.

What emerges from this study is a revelation of concentration-driven phase segregation phenomena right at the interfacial layers, termed high-concentration interfacial layers (HCILs). These HCILs form as LiPSs aggregate in the immediate vicinity of the electrode surface during cycling, dramatically altering the local reaction environment. This segregation is not merely a passive occurrence; it actively directs charge-transfer dynamics by establishing competitive conditions between surface-mediated and solution-based pathways. The delicate interplay in these zones influences where and how lithium sulfide (Li₂S) nucleates and grows, directly impacting the battery’s capacity retention and cycling stability.

Complementing the microscopy observations, computational explorations using density functional theory (DFT) provide a molecular-level understanding of how LiPS clusters modify their electronic structure upon aggregation. The study identifies that the molecular geometries and orbital hybridizations evolve as LiPSs coalesce, resulting in enhanced electronic interactions that facilitate charge transfer through the concentrated clusters. This phenomenon fundamentally challenges previously held models which treated LiPS species largely as isolated entities, offering a new paradigm that accounts for collective behavior in highly concentrated solutions.

The practical implications of these mechanistic insights are far-reaching. By comprehending how HCILs govern interfacial reaction pathways, the researchers have engineered electrodes that strategically balance surface and solution reactions amidst high LiPS concentrations. These meticulously optimized electrodes enable impressive fast-charging capabilities—reaching rates up to 4 C with current densities of 26.8 mA cm⁻²—without compromising energy density, which itself surges beyond 400 Wh kg⁻¹. Such milestones represent a substantial leap forward in the achievable performance metrics for Li–S battery technology.

This study’s significance extends beyond the immediate Li–S chemistry, addressing a broader challenge in electrochemical energy conversion: capturing and controlling complex interfacial phenomena under dynamically varying concentrations. The in situ liquid-cell electron microscopy method establishes a powerful approach for observing reactive species and phase evolution directly in their native electrochemical environment. As such, it holds promise to transform research across a host of energy storage and catalysis systems where interfacial reactions dictate overall function.

Notably, this work also clarifies why lean electrolyte conditions—essential for practical high-energy devices—have historically been so difficult to optimize. The rich detail uncovered concerning phase segregation and charge transfer competition suggests that managing HCIL formation and stability may be the key to unlocking robust Li₂S deposition and dissolution cycles. Hence, this strategy could mitigate common pitfalls like cathode passivation and capacity fading, which have limited long-term operational viability.

The fusion of experimental visualization with robust theoretical modeling provides a comprehensive framework that future researchers and engineers can exploit to rationally design electrode interfaces. Moving past empirical trial-and-error, the ability to predict and control molecular aggregation behavior and its effects on electronic properties opens new avenues for tuning battery chemistry on an atomic scale. Such sophistication could accelerate the sustainable deployment of lithium–sulfur batteries within electric vehicles, grid storage, and portable electronics.

Moreover, the study emphasizes the profound impact of molecular-level phenomena on macroscopic performance metrics such as charging speed and energy density. By showing that the electrochemical environment at the nanoscale directly modulates reaction kinetics and phase evolution, this research bridges a critical knowledge gap between fundamental science and technological application. It highlights the necessity for integrated approaches combining real-time imaging, theoretical insight, and materials engineering.

Looking ahead, the insights gained are poised to influence material selection, electrolyte formulation, and cell architecture design. Tailoring these elements to favor desirable HCIL characteristics could lead to batteries that not only charge rapidly and store vast amounts of energy but also maintain stability over many cycles. Furthermore, the foundational principles elucidated may inspire innovations beyond lithium–sulfur systems, potentially transforming a range of emerging battery chemistries where interface complexity rules.

In conclusion, this remarkable study marks a pivotal advance in understanding and harnessing the subtleties of interfacial charge transfer within lithium–sulfur batteries. By unraveling the competitive reactions shaped by concentration gradients and molecular aggregation, it charts a pathway toward high-performance batteries ready for real-world demands. As energy storage solutions continue to underpin the clean energy transition, such elegant fusion of fundamental science and engineering innovation will be indispensable for propelling next-generation technologies.

---

Subject of Research: Charge transfer and reaction mechanisms at solid–liquid interfaces in lithium–sulfur batteries.

Article Title: Revealing competitive interfacial reactions in high-energy Li–S batteries.

Article References:
Zhou, S., Pei, F., Zheng, Q. et al. Revealing competitive interfacial reactions in high-energy Li–S batteries. Nature (2026). https://doi.org/10.1038/s41586-025-09473-2

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41586-025-09473-2

In a groundbreaking advancement in neuroscience technology, researchers from the Aerospace Information Research Institute at the Chinese Academy of Sciences have unveiled a state-of-the-art dual-mode wireless microsystem designed to simultaneously monitor electrophysiological activity and dopamine-related electrochemical signals within the brain. This innovative platform promises to illuminate the intricate neural mechanisms underlying pharmacological effects on cortical circuits by capturing real-time electrical and chemical brain dynamics, a feat that has long eluded scientists due to technical constraints.

Neuroscientific investigations often grapple with the challenge of correlating multidimensional neural signals that operate on different modalities. Electrophysiological recordings capture rapid neuronal spikes and local field potentials (LFPs), presenting a temporal resolution ideal for observing immediate neuronal events. However, these signals alone fail to convey the chemical milieu shaping neural behavior. Neurotransmitter dynamics, especially dopamine, play a crucial role in modulating brain function but require sensitive electrochemical detection methods for accurate monitoring. Historically, research platforms have predominantly focused on one modality—either electrophysiological or neurochemical—making it difficult to obtain a holistic understanding of brain states or drug effects.

The newly developed dual-mode microelectrode array tackles this limitation through a sophisticated electrode design. Using platinum nanoparticles (PtNPs) and poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS), the researchers engineered electrophysiological sites with enhanced conductivity and stability for precise spike and LFP recordings. Simultaneously, an electrochemical site tailored for dopamine sensing incorporates additional modifications with reduced graphene oxide (rGO) and Nafion, constructing a PtNPs/PEDOT:PSS/rGO/Nafion composite. This multi-layered structure significantly amplifies electrochemical sensitivity and ensures selectivity against common interferents such as uric acid, serotonin, ascorbic acid, and lactic acid.

On the hardware frontier, the team implemented a hybrid acquisition system that integrates a specialized electrophysiological chip alongside the AD5941 electrochemical front end. An intelligent dual-controller architecture comprising a field-programmable gate array (FPGA) paired with an ESP32 microcontroller orchestrates independent yet synchronized data capture and wireless transmission from both signal modalities. Critical to minimizing crosstalk and data corruption, electrophysiological and electrochemical data streams are transmitted simultaneously but via separate TCP ports. This architectural choice guarantees the temporal alignment and integrity of neural datasets, enabling researchers to dissect the interplay between electrical spikes, LFPs, and dopamine fluctuations with millisecond precision.

The comprehensive calibration and validation of this microsystem were first conducted in vitro. Dopamine calibration curves revealed a robust and linear electrochemical response, confirming the device’s sensitivity and dynamic range. Notably, selectivity tests demonstrated the system’s ability to discriminate dopamine oxidation currents amidst a cocktail of neurochemical interferents, ensuring fidelity in complex biological environments. Furthermore, wireless transmission integrity was rigorously assessed, demonstrating accurate data delivery across distances up to 25 meters with negligible latency or packet loss, underscoring the device’s suitability for freely moving animal experiments without tethers.

Translating these advances into a live animal model, the researchers implanted the dual-mode microsystem into the prelimbic (PrL) cortex of rats. This brain region is integral to executive functions and is sensitive to neuropharmacological modulation. By administering dexmedetomidine—a sedative with known but paradoxical and poorly understood effects on cortical activity—the team pursued a dynamic interrogation of neural electrical firing patterns alongside dopamine fluctuations. This sophisticated approach exposed nuanced dose-dependent changes: higher doses correlated with reduced spike firing rates and dampened peak-to-peak amplitudes, suppressed overall LFP power, increased delta-frequency activity (associated with decreased arousal), and reduced gamma oscillations, indicative of a reconfigured cortical state consistent with sedation.

Simultaneously, electrochemical monitoring unveiled an increase in amperometric signals related to dopamine concentrations as dexmedetomidine dosage escalated. This parallel observation of neurochemical enhancement accompanying electrophysiological suppression substantiates the microsystem’s capability to capture the complex, multifaceted neural correlates of sedation. Importantly, control saline conditions elicited minimal changes, affirming system specificity and the physiological relevance of the recorded responses. These findings reveal the microsystem’s potential as a powerful investigative tool for understanding the neurochemical underpinnings of anesthetic action and cortical state transitions.

The scientific implications of this dual-mode wireless microsystem are profound. Unlike prior single-modality or tethered platforms, this technology conserves 32 independent electrophysiological channels at high sampling rates while integrating dopamine-sensitive electrochemical pathways within the same device footprint. The dual-TCP wireless architecture enables real-time, synchronized acquisition and visualization of electrical and chemical signals, overcoming longstanding barriers in multimodal neural monitoring. Such comprehensive systems are invaluable for probing the mechanistic interactions between neural circuit activity and neurotransmitter dynamics under pharmacological challenges.

Looking forward, despite its remarkable performance, the current microsystem has limitations that present rich avenues for refinement. The modest in vivo sample size tempers broad generalization of the reported electrophysiological and dopamine-related observations. Amperometric readings in vivo remain susceptible to confounding factors such as electrode fouling, baseline drift, shifts in local pH or oxygenation, tissue inflammatory responses, and reference electrode stability. Thus, the data are best interpreted as dopamine-correlated signals rather than exact dopamine quantifications in extracellular space. Furthermore, the system currently relies on commercial electronic components, which constrain further miniaturization. It also lacks integrated stimulation or closed-loop modulation functionalities, which are critical for advanced neuromodulation studies.

Future developments aspire to embed dedicated, custom-fabricated integrated circuits that will shrink device size and power consumption. Incorporation of multimodal closed-loop control systems will enable responsive neurochemical-electrical feedback interventions, enhancing therapeutic and experimental utility. Expanding recording capacity to encompass multiple brain regions simultaneously will provide a more comprehensive spatial map of neurophysiological network dynamics. Cross-validation with orthogonal neurochemical detection modalities could further bolster confidence in dopamine measurements. Together, these advances would propel the technology from a sophisticated measurement tool to an instrumental platform for neurological disease research, neurorehabilitation, and cognitive neuroscience.

The research team responsible for this innovation includes Peiyao Jiao, Yilin Song, Jin Shan, Yu Liu, Qianli Jia, Qi Li, Ying Wang, Yan Luo, Pengfei Zhao, Juntao Liu, Zhenchang Wang, Mixia Wang, and Xinxia Cai. Their work represents a significant leap toward decrypting the intertwined electrical and chemical language of the brain in vivo, promising to inspire future explorations into neural circuit regulation and pharmacodynamics.

This pioneering study titled “A Dual-Mode Wireless Microsystem for Monitoring Dopamine and Spike Changes with Dexmedetomidine” was published on May 21, 2026, in the journal Cyborg and Bionic Systems. It was supported by funding from the National Natural Science Foundation of China, the Major Program of Scientific and Technical Innovation 2030, the Chinese Academy of Sciences Joint Foundation Program, and the Natural Science Foundation of Beijing.

Subject of Research: Dual-mode wireless monitoring of electrophysiological and dopamine-related electrochemical signals in vivo under pharmacological modulation.

Article Title: A Dual-Mode Wireless Microsystem for Monitoring Dopamine and Spike Changes with Dexmedetomidine

News Publication Date: May 21, 2026

Image Credits: Peiyao Jiao, Aerospace Information Research Institute, Chinese Academy of Sciences

Keywords

Neural monitoring, dopamine sensing, electrophysiology, wireless microsystem, dexmedetomidine, neurochemistry, brain-computer interfaces, electrode modification, dual-mode recording, neuropharmacology, local field potentials, neural circuits